Clinical trial
Serological and Functional Impact of COVID-19 Vaccination on the Maternal Fetal Unit and Infant Immunity
NCT05543993 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Serological and Functional Impact of COVID-19 Vaccination on the Maternal Fetal Unit and Infant Immunity
- Lead sponsor
- Thomas Jefferson University
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 29, 2022
- Completion date
- June 10, 2024
- Enrollment
- 150 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.